These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1849196)

  • 1. [Prevalence of HCV antibodies from mass survey in Shimane Prefecture].
    Ikeda S; Uchida M; Fukumoto S; Shimada Y
    Nihon Rinsho; 1991 Feb; 49(2):378-82. PubMed ID: 1849196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of the HCV associated markers among blood donors in Japan].
    Yoshizawa H; Tanaka J; Ohhori K; Iizuka H; Tango T; Watanabe J; Aoyama K; Mizui M
    Nihon Rinsho; 1991 Feb; 49(2):357-65. PubMed ID: 1901371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].
    Kamimura T; Miyajima T; Okoshi S; Kojima H; Asakura H; Shimotono K
    Nihon Rinsho; 1991 Feb; 49(2):409-11. PubMed ID: 1849201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of HCV-ELISA using synthetic peptide].
    Takahashi T; Hayashi N; Shikata T
    Nihon Rinsho; 1991 Feb; 49(2):347-50. PubMed ID: 1849192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
    Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of anti-HCV antibody positive hepatocellular carcinoma].
    Hayashi S; Tanaka S; Wakashima M; Saeki S; Tanaka T; Shibayama T; Otake H; Hattori N
    Nihon Rinsho; 1991 Feb; 49(2):432-8. PubMed ID: 1849205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
    Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
    Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV transmission after receiving anti-c100-negative blood units.
    Inaba S; Fukuda M; Okochi K; Irita Y; Tokunaga K; Kiyokawa H; Maeda Y
    Lancet; 1991 Jun; 337(8753):1354. PubMed ID: 1709435
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of serum hepatitis C virus RNA using the polymerase chain reaction assay].
    Yanagi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1991 Feb; 49(2):292-9. PubMed ID: 1849185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interpretation of Ortho HCV Ab ELISA test results by chiron HCV recombinant immunoblot assay].
    Yahagi N; Kitsugi K
    Rinsho Byori; 1991 Jan; 39(1):26-33. PubMed ID: 1848912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of hepatitis C related markers and control of hepatitis C infection].
    Yoshizawa H
    Nihon Koshu Eisei Zasshi; 1992 Aug; 39(8):441-4. PubMed ID: 1327295
    [No Abstract]   [Full Text] [Related]  

  • 13. [ Non-A, non-B hepatitis: current developments--HCV, HEV and others].
    Lavanchy D
    Rev Med Suisse Romande; 1991 Mar; 111(3):241-3. PubMed ID: 1709514
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigation of anti-hepatitis C virus in the sera of different populations of Beijing].
    Zhonghua Yi Xue Za Zhi; 1992 Jan; 72(1):18-20, 62-3. PubMed ID: 1374286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HCV-antibodies and HCV-RNA in donor blood in Tokushima Prefecture.
    Honda H; Hibino S; Nii C; Horikita M; Kamamura M; Nishikado T; Horie T; Okahisa T; Shibata H; Shimizu I
    Tokushima J Exp Med; 1994 Jun; 41(1-2):9-15. PubMed ID: 7524193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against the structural and nonstructural components of HCV in i.v. drug abusers].
    Tanzi ML; Zoni R; Bracchi U; Bombarda G; Volpicelli A; Bellelli E
    Ann Ig; 1994; 6(1):13-7. PubMed ID: 7530968
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infection of C type hepatitis virus in patients with alcoholism. Studied by serum HCV antibody of C100-3 and 2nd generation].
    Ishii K; Sata M; Furudera S; Tanaka S; Kumashiro R; Tanikawa K; Abe H; Ishibashi M; Yokoyama T
    Arukoru Kenkyuto Yakubutsu Ison; 1992 Apr; 27(2):180-8. PubMed ID: 1316746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.